1. Home
  2. RCG vs BIVI Comparison

RCG vs BIVI Comparison

Compare RCG & BIVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCG
  • BIVI
  • Stock Information
  • Founded
  • RCG 1994
  • BIVI 2013
  • Country
  • RCG United States
  • BIVI United States
  • Employees
  • RCG N/A
  • BIVI N/A
  • Industry
  • RCG Investment Managers
  • BIVI Biotechnology: Pharmaceutical Preparations
  • Sector
  • RCG Finance
  • BIVI Health Care
  • Exchange
  • RCG Nasdaq
  • BIVI Nasdaq
  • Market Cap
  • RCG 18.6M
  • BIVI 15.0M
  • IPO Year
  • RCG N/A
  • BIVI N/A
  • Fundamental
  • Price
  • RCG $2.60
  • BIVI $7.48
  • Analyst Decision
  • RCG
  • BIVI
  • Analyst Count
  • RCG 0
  • BIVI 0
  • Target Price
  • RCG N/A
  • BIVI N/A
  • AVG Volume (30 Days)
  • RCG 5.9K
  • BIVI 60.7K
  • Earning Date
  • RCG 01-01-0001
  • BIVI 05-12-2025
  • Dividend Yield
  • RCG 0.98%
  • BIVI N/A
  • EPS Growth
  • RCG N/A
  • BIVI N/A
  • EPS
  • RCG N/A
  • BIVI N/A
  • Revenue
  • RCG N/A
  • BIVI N/A
  • Revenue This Year
  • RCG N/A
  • BIVI N/A
  • Revenue Next Year
  • RCG N/A
  • BIVI N/A
  • P/E Ratio
  • RCG N/A
  • BIVI N/A
  • Revenue Growth
  • RCG N/A
  • BIVI N/A
  • 52 Week Low
  • RCG $1.52
  • BIVI $6.20
  • 52 Week High
  • RCG $1.90
  • BIVI $75.00
  • Technical
  • Relative Strength Index (RSI)
  • RCG 45.66
  • BIVI 42.04
  • Support Level
  • RCG $2.57
  • BIVI $7.24
  • Resistance Level
  • RCG $2.71
  • BIVI $8.40
  • Average True Range (ATR)
  • RCG 0.05
  • BIVI 0.73
  • MACD
  • RCG -0.01
  • BIVI 0.05
  • Stochastic Oscillator
  • RCG 31.25
  • BIVI 36.94

About RCG RENN Fund Inc

RENN Fund Inc is active in the financial services domain. It is a a registered, non-diversified, closed-end management investment company formed to provide return through capital appreciation and income by a long-term, value-oriented investment process that invests in a wide variety of financial instruments, including but not limited to, common stocks, fixed-income securities including convertible and non-convertible debt securities or loans, distressed debt, warrants, and preferred stock, exchange-traded funds and exchange-traded notes, and other instruments. It invests in various industries, including communication services, surgical and medical instruments and apparatus, oil and gas, medical chemicals, botanical products, etc.

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

Share on Social Networks: